Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1985 Jan;48(1):50–57. doi: 10.1136/jnnp.48.1.50

Cerebrospinal fluid vasopressin in neurological and psychiatric disorders.

P S Sørensen, A Gjerris, M Hammer
PMCID: PMC1028182  PMID: 3973621

Abstract

Vasopressin was determined in CSF and plasma of 243 patients with different neurological and psychiatric disorders, including control patients. CSF vasopressin was significantly higher in patients with high pressure hydrocephalus, intracranial tumour, benign intracranial hypertension, intracranial haemorrhage, ischaemic stroke, and craniocerebral trauma. In patients with primary degenerative dementia, CSF vasopressin was lower than in control patients. Among patients with psychiatric disorders, CSF vasopressin was increased in manic patients, while in patients with depression CSF concentration of this hormone did not differ from that found in controls. However, an increase in CSF vasopressin level was found in patients recovering from a depression. The clinical significance of changes in CSF vasopressin concentrations in groups of patients with neurological and psychiatric disorders is still unknown.

Full text

PDF
50

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ang V. T., Jenkins J. S. Blood-cerebrospinal fluid barrier to arginine-vasopressin, desmopressin and desglycinamide arginine-vasopressin in the dog. J Endocrinol. 1982 Jun;93(3):319–325. doi: 10.1677/joe.0.0930319. [DOI] [PubMed] [Google Scholar]
  2. Bech P., Bolwig T. G., Kramp P., Rafaelsen O. J. The Bech-Rafaelsen Mania Scale and the Hamilton Depression Scale. Acta Psychiatr Scand. 1979 Apr;59(4):420–430. doi: 10.1111/j.1600-0447.1979.tb04484.x. [DOI] [PubMed] [Google Scholar]
  3. Brownfield M. S., Kozlowski G. P. The hypothalamo-choroidal tract. I. Immunohistochemical demonstration of neurophysin pathways to telencephalic choroid plexuses and cerebrospinal fluid. Cell Tissue Res. 1977 Mar 1;178(1):111–127. doi: 10.1007/BF00232829. [DOI] [PubMed] [Google Scholar]
  4. Buijs R. M., Swaab D. F., Dogterom J., van Leeuwen F. W. Intra- and extrahypothalamic vasopressin and oxytocin pathways in the rat. Cell Tissue Res. 1978 Jan 31;186(3):423–433. doi: 10.1007/BF00224932. [DOI] [PubMed] [Google Scholar]
  5. Børgesen S. E., Gjerris F., Srensen S. C. The resistance to cerebrospinal fluid absorption in humans. A method of evaluation by lumbo-ventricular perfusion, with particular reference to normal pressure hydrocephalus. Acta Neurol Scand. 1978 Jan;57(1):88–96. doi: 10.1111/j.1600-0404.1978.tb04500.x. [DOI] [PubMed] [Google Scholar]
  6. DE WIED D. THE INFLUENCE OF THE POSTERIOR AND INTERMEDIATE LOBE OF THE PITUITARY AND PITUITARY PEPTIDES ON THE MAINTENANCE OF A CONDITIONED AVOIDANCE RESPONSE IN RATS. Int J Neuropharmacol. 1965 May;4:157–167. doi: 10.1016/0028-3908(65)90005-5. [DOI] [PubMed] [Google Scholar]
  7. Durso R., Fedio P., Brouwers P., Cox C., Martin A. J., Ruggieri S. A., Tamminga C. A., Chase T. N. Lysine vasopressin in Alzheimer disease. Neurology. 1982 Jun;32(6):674–677. doi: 10.1212/wnl.32.6.674. [DOI] [PubMed] [Google Scholar]
  8. Dóczi T., Szerdahelyi P., Gulya K., Kiss J. Brain water accumulation after the central administration of vasopressin. Neurosurgery. 1982 Sep;11(3):402–407. doi: 10.1227/00006123-198209000-00011. [DOI] [PubMed] [Google Scholar]
  9. Franceschi M., Tancredi O., Savio G., Smirne S. Vasopressin and physostigmine in the treatment of amnesia. Eur Neurol. 1982;21(6):388–391. doi: 10.1159/000115511. [DOI] [PubMed] [Google Scholar]
  10. Garcia H., Kaplan S. L., Feigin R. D. Cerebrospinal fluid concentration of arginine vasopressin in children with bacterial meningitis. J Pediatr. 1981 Jan;98(1):67–70. doi: 10.1016/s0022-3476(81)80537-9. [DOI] [PubMed] [Google Scholar]
  11. Gold P. W., Goodwin F. K., Reus V. I. Vasopressin in affective illness. Lancet. 1978 Jun 10;1(8076):1233–1236. doi: 10.1016/s0140-6736(78)92467-4. [DOI] [PubMed] [Google Scholar]
  12. Hammer M., Ladefoged J., Olgaard K. Relationship between plasma osmolality and plasma vasopressin in human subjects. Am J Physiol. 1980 Apr;238(4):E313–E317. doi: 10.1152/ajpendo.1980.238.4.E313. [DOI] [PubMed] [Google Scholar]
  13. Hammer M. Radioimmunoassay of 8-arginine-vasopressin (antidiuretic hormone) in human plasma. Scand J Clin Lab Invest. 1978 Dec;38(8):707–716. doi: 10.1080/00365517809104877. [DOI] [PubMed] [Google Scholar]
  14. Hammer M., Sørensen P. S., Gjerris F., Larsen K. Vasopressin in the cerebrospinal fluid of patients with normal pressure hydrocephalus and benign intracranial hypertension. Acta Endocrinol (Copenh) 1982 Jun;100(2):211–215. doi: 10.1530/acta.0.1000211. [DOI] [PubMed] [Google Scholar]
  15. Hawthorn J., Ang V. T., Jenkins J. S. Localization of vasopressin in the rat brain. Brain Res. 1980 Sep 15;197(1):75–81. doi: 10.1016/0006-8993(80)90435-7. [DOI] [PubMed] [Google Scholar]
  16. Jenkins J. S., Mather H. M., Ang V. Vasopressin in human cerebrospinal fluid. J Clin Endocrinol Metab. 1980 Feb;50(2):364–367. doi: 10.1210/jcem-50-2-364. [DOI] [PubMed] [Google Scholar]
  17. Jenkins J. S., Mather H. M., Coughlan A. K., Jenkins D. G. Desmopressin and desglycinamide vasopressin in post-traumatic amnesia. Lancet. 1981 Jan 3;1(8210):39–39. doi: 10.1016/s0140-6736(81)90137-9. [DOI] [PubMed] [Google Scholar]
  18. Legros J. J., Gilot P., Seron X., Claessens J., Adam A., Moeglen J. M., Audibert A., Berchier P. Influence of vasopressin on learning and memory. Lancet. 1978 Jan 7;1(8054):41–42. doi: 10.1016/s0140-6736(78)90386-0. [DOI] [PubMed] [Google Scholar]
  19. Mann D. M., Yates P. O., Bansal D. V., Marshall D. J. Hypothalamus and dementia. Lancet. 1981 Feb 14;1(8216):393–394. doi: 10.1016/s0140-6736(81)91721-9. [DOI] [PubMed] [Google Scholar]
  20. Mather H. M., Ang V., Jenkins J. S. Vasopressin in plasma and CSF of patients with subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 1981 Mar;44(3):216–219. doi: 10.1136/jnnp.44.3.216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Noto T., Kato N., Inoue K., Kitabayashi M., Nakajima T. The levels of vasopressin in cerebrospinal fluid of patients with alcoholism. Endocrinol Jpn. 1982 Feb;29(1):121–124. doi: 10.1507/endocrj1954.29.121. [DOI] [PubMed] [Google Scholar]
  22. Noto T., Nakajima T., Saji Y., Nagawa Y. Effect of vasopressin on intracranial pressure of rabbit. Endocrinol Jpn. 1978 Dec;25(6):591–596. doi: 10.1507/endocrj1954.25.591. [DOI] [PubMed] [Google Scholar]
  23. Oram J. J., Edwardson J., Millard P. H. Investigation of cerebrospinal fluid neuropeptides in idiopathic senile dementia. Gerontology. 1981;27(4):216–223. doi: 10.1159/000212476. [DOI] [PubMed] [Google Scholar]
  24. Raichle M. E., Grubb R. L., Jr Regulation of brain water permeability by centrally-released vasopressin. Brain Res. 1978 Mar 17;143(1):191–194. doi: 10.1016/0006-8993(78)90766-7. [DOI] [PubMed] [Google Scholar]
  25. Reichert W. H., Blass J. P. A placebo-controlled trial shows no effect of vasopressin on recovery from closed head injury. Ann Neurol. 1982 Oct;12(4):390–392. doi: 10.1002/ana.410120412. [DOI] [PubMed] [Google Scholar]
  26. Reid A. C., Morton J. J. Arginine vasopressin levels in cerebrospinal fluid in neurological disease. J Neurol Sci. 1982 May;54(2):295–301. doi: 10.1016/0022-510x(82)90190-3. [DOI] [PubMed] [Google Scholar]
  27. Rossor M. N., Iversen L. L., Hawthorn J., Ang V. T., Jenkins J. S. Extrahypothalamic vasopressin in human brain. Brain Res. 1981 Jun 15;214(2):349–355. doi: 10.1016/0006-8993(81)91199-9. [DOI] [PubMed] [Google Scholar]
  28. Rossor M. N., Iversen L. L., Mountjoy C. Q., Roth M., Hawthorn J., Ang V. Y., Jenkins J. S. Arginine vasopressin and choline acetyltransferase in brains of patients with Alzheimer type senile dementia. Lancet. 1980 Dec 20;2(8208-8209):1367–1368. doi: 10.1016/s0140-6736(80)92428-9. [DOI] [PubMed] [Google Scholar]
  29. SCHUMACHER G. A., BEEBE G., KIBLER R. F., KURLAND L. T., KURTZKE J. F., MCDOWELL F., NAGLER B., SIBLEY W. A., TOURTELLOTTE W. W., WILLMON T. L. PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS. Ann N Y Acad Sci. 1965 Mar 31;122:552–568. doi: 10.1111/j.1749-6632.1965.tb20235.x. [DOI] [PubMed] [Google Scholar]
  30. Sundquist J., Forsling M. L., Olsson J. E., Akerlund M. Cerebrospinal fluid arginine vasopressin in degenerative disorders and other neurological diseases. J Neurol Neurosurg Psychiatry. 1983 Jan;46(1):14–17. doi: 10.1136/jnnp.46.1.14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Sørensen P. S., Gjerris F., Hammer M. Cerebrospinal fluid vasopressin and increased intracranial pressure. Ann Neurol. 1984 May;15(5):435–440. doi: 10.1002/ana.410150506. [DOI] [PubMed] [Google Scholar]
  32. Sørensen P. S., Hammer M., Bolwig T. G. Vasopressin release during electroconvulsive therapy. Psychoneuroendocrinology. 1982;7(4):303–308. doi: 10.1016/0306-4530(82)90034-8. [DOI] [PubMed] [Google Scholar]
  33. Sørensen P. S., Hammer M., Gjerris F. Cerebrospinal fluid vasopressin in benign intracranial hypertension. Neurology. 1982 Nov;32(11):1255–1259. doi: 10.1212/wnl.32.11.1255. [DOI] [PubMed] [Google Scholar]
  34. Sørensen P. S., Hammer M., Vorstrup S., Gjerris F. CSF and plasma vasopressin concentrations in dementia. J Neurol Neurosurg Psychiatry. 1983 Oct;46(10):911–916. doi: 10.1136/jnnp.46.10.911. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Tsuji M., Takahashi S., Akazawa S. CSF Vasopressin and cyclic nucleotide concentrations in senile dementia. Psychoneuroendocrinology. 1981;6(2):171–176. doi: 10.1016/0306-4530(81)90009-3. [DOI] [PubMed] [Google Scholar]
  36. Weingartner H., Gold P., Ballenger J. C., Smallberg S. A., Summers R., Rubinow D. R., Post R. M., Goodwin F. K. Effects of vasopressin on human memory functions. Science. 1981 Feb 6;211(4482):601–603. doi: 10.1126/science.7455701. [DOI] [PubMed] [Google Scholar]
  37. Weingartner H., Kaye W., Gold P., Smallberg S., Peterson R., Gillin J. C., Ebert M. Vasopressin treatment of cognitive dysfunction in progressive dementia. Life Sci. 1981 Dec 28;29(26):2721–2726. doi: 10.1016/0024-3205(81)90531-2. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES